M. Lacouture

Oncology · 2006–2021

A researcher in the Science corpus: 4 papers; trusts 8 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Lacouture trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Y. Yarden
  2. M. Sliwkowski
  3. N. Hynes
  4. J. Mendelsohn
  5. Elaine Fuchs

Papers from M. Lacouture's perspective

Ordered by how strongly the researchers M. Lacouture trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Untangling the ErbB signalling network (Nature reviews. Molecular cell biology)
  2. ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors (Nature Reviews. Cancer)
  3. Getting under the skin of epidermal morphogenesis (Nature reviews genetics)
  4. PD-1 blockade in tumors with mismatch repair deficiency. (Journal of Clinical Oncology)
  5. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
  6. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised,… (The Lancet Oncology)
  7. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  8. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma (New England Journal of Medicine)
  9. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients (Nature)
  10. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer (New England Journal of Medicine)

Their papers